Ghost Tree Capital’s Gilead Sciences GILD Stock Holding History

Ghost Tree Capital’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q1	–	Sell	-750,000	Closed	-$5.63M	–	71
2013 Q4	$5.63M	Buy	+750,000	New	+$52.2M	3.47%	6

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Ghost Tree Capital's GILD Position: Q3 2020 in Review

Ghost Tree Capital sold out of Gilead Sciences (GILD) in Q3 2020, closing a stake of 25,000 shares — an estimated $1.92M sold.

Ghost Tree Capital first reported a position in GILD in Q4 2013 and held it in 6 quarters. The position peaked at $10.1M in Q4 2013. 1,538 funds tracked by Wall St. Rank hold GILD as of Q3 2020.

Ghost Tree Capital reported no remaining Gilead Sciences position as of Q3 2020 after selling out during the quarter.
Ghost Tree Capital sold 25,000 Gilead Sciences shares in Q3 2020, an estimated $1.92M.
Ghost Tree Capital first reported a position in Gilead Sciences in Q4 2013 and held it in 6 quarters.
Ghost Tree Capital's Gilead Sciences position peaked at $10.1M in Q4 2013.
1,538 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2020.

Based on Ghost Tree Capital's 13F filing for Q3 2020, filed 16 Nov 2020.